Janux Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Janux Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Janux Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 52.2M shares, a 24.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 52.2M +10.3M +24.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 51.8M +10M +24% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 46.3M +4.64M +11.1% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 46.2M +4.6M +11.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 41.9M +366K +0.88% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 41.8M +409K +0.99% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 41.6M +373K +0.91% Dec 31, 2022 10-K 2024-03-08
Q3 2022 41.6M +379K +0.92% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 41.5M +407K +0.99% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 41.4M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 41.2M +40.2M +3841% Dec 31, 2021 10-K 2023-03-10
Q3 2021 41.2M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 41.1M Jun 30, 2021 10-Q 2021-08-10
Q4 2020 1.05M Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.